To see all protocols that comply with the WHO Essential Medicine List 

This protocol is based on limited evidence; refer to the evidence section of this protocol for more information.

Check for clinical trials in this patient group. Link to Australian Clinical Trials website

  • eviQ predominantly uses the term stereotactic ablative radiation therapy (SABR) and considers this to be interchangeable with stereotactic body radiation therapy (SBRT) and stereotactic radiation therapy (SRT).
  • Requirements to safely administer SABR include specialised equipment, strict QA procedures, comprehensive departmental protocols, and a credentialed and experienced multidisciplinary team.r
  • For more information about quality and safety refer to the ASTRO white paper, AAPM TG101-SBRT guidelines, AAPM TG 76 Motion management and FRO Guidelines for Safe Practice of Stereotactic Body (Ablative) Radiation Therapy.rrrr

The information contained in this protocol is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted approaches to treatment. Any clinician (medical oncologist, haematologist, radiation oncologist, medical physicist, radiation therapist, pharmacist or nurse) seeking to apply or consult this protocol is expected to use independent clinical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information sources. Use is subject to eviQ’s disclaimer available at www.eviQ.org.au

Send feedback for this page


First approved:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

https://www.eviq.org.au/p/4026

29 Mar 2024